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IL-6-deﬁcient transgenic mice (IL-6 KO) display signiﬁcantly delayed cutaneous wound healing. To further
elucidate the role of IL-6 in skin wound healing, epidermal keratinocyte and dermal ﬁbroblast cells were isolated
from neonatal IL-6 KO mice and treated with rmIL-6. It was found that rmIL-6 alone did not signiﬁcantly modulate
the proliferation or migration of cultured IL-6 KO keratinocytes. rmIL-6, however, signiﬁcantly induced the
migration of IL-6 KO keratinocytes (up to 5-fold) when co-cultured with dermal ﬁbroblasts. Culture supernatants
from IL-6-treated ﬁbroblasts were also found to induce the migration of keratinocytes to a similar degree. Genomics
analysis of treated ﬁbroblasts indicated that rmIL-6 does not induce any known soluble keratinocyte migratory
factors. rmIL-6 treatment of ﬁbroblast, however, induced a rapid and sustained phosphorylation of STAT3 protein.
These data indicate that IL-6 could inﬂuence wound healing by inducing keratinocyte migration through the
production of a soluble ﬁbroblast-derived factor, and its activity may be associated with STAT3 activation.
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In the United States, over 6 million individuals develop
chronic skin ulcers annually (Singer and Clark, 1999), and
the restoration or augmentation of cutaneous wound
healing has long been an elusive goal for health care
professionals. Based on gross morphology, the skin can be
divided into two major components: the epidermis and
dermis. The epidermis is primarily made up of keratino-
cytes, which form stratified layers of increasingly differ-
entiated cells, terminating in the outermost tough, keratin
layer known as the stratum corneum. Beneath the epider-
mis, the dermis is predominantly composed of an elastic
collagen matrix, which contains numerous cell types
including fibroblasts, and immune cells such as Langerhans
cells. Following trauma to the skin, these diverse cell types
must interact and cooperate in an orderly sequence of
events that, when simplified, includes coagulation, inflam-
mation, formation of a provisional collagen matrix (granula-
tion tissue), re-epithelialization, and remodeling (for a
review, see Bello and Phillips, 2000). While much research
has been accomplished to describe the many aspects of
dermal and epidermal cell activity during wound healing, the
precise mechanisms of the interplay between dermal and
epidermal tissue during this complex process are not
entirely known.
IL-6 is a pleiotropic cytokine that is involved in the growth
and differentiation of numerous cell types, including those
of dermal and epidermal origin (Sehgal, 1990). In the skin it
is produced primarily by epidermal keratinocytes, while
macrophages, Langerhans cells, and fibroblasts in the
dermis represent other sources of the cytokine (Paquet
and Pierard, 1996). Increased levels of IL-6 have been
associated with a number of skin pathologies, such as
psoriasis (Grossman et al, 1989), scleroderma (Koch et al,
1993), and systemic lupus erythematosus (Fugger et al,
1989). Overexpression of IL-6 in the skin of normal rats
induces epidermal proliferation and inflammation (Sawa-
mura et al, 1998), while transgenic mice overexpressing IL-6
display little more than a thickened stratum corneum
(Turksen et al, 1992).
While it seems that the role of IL-6 is well established in
disease conditions, relatively little is known about its role in
skin repair. It has been well documented that an inflamma-
tory response following cutaneous wounding is a pre-
requisite for healing, and inflammatory cytokines, such as
IL-6, might be intimately involved in this process. For
instance, glucocorticoids decrease the expression of
proinflammatory cytokines in wounds, and interfere with
wound repair (Hubner and Werner, 1996). Furthermore,
elimination of macrophages, a major source of inflammatory
cytokines, from a wounded site delays wound healing
(Leibovich and Ross, 1975). IL-6 is readily detected in
cutaneous wounds (Hubner and Werner, 1996; Kondo and
Ohshima, 1996), and in the supernatant from keratinocyte
cultures subjected to in vitro wounds (Sugawara et al, 2001).
Streptozotocin-induced diabetic mice displayed delayed
wound healing, and low levels of IL-6 in wound fluid (Fahey
et al, 1991). IL-6 expression in dermal fibroblasts also
decreases with age, which may contribute to delayed
cutaneous wound healing in the elderly (Goodman and
Stein, 1994). Most significantly, IL-6-deficient transgenic
mice (IL-6 KO) display significantly delayed cutaneous
wound healing compared to wild-type control animals
(Gallucci et al, 2001b; Lin et al, 2003). Wounds from IL-6-
deficient mice displayed multiple defects including delayed
re-epithelialization, greatly decreased granulation tissue,
Abbreviations: FCM, IL-6 (10ng per mL)-treated fibroblast-condi-
tioned medium; KGM, complete keratinocyte growth medium;
SFKGM, serum-free, growth factor free, keratinocyte growth
medium
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inhibited neovasculariziation, and required up to 3-fold
longer to heal.
In this article, we describe a cooperative interaction
between dermal and epidermal cells that sheds light on the
role of IL-6 during wound healing. We detail the effects of
rmIL-6 on dermal and epidermal cell proliferation and
migration in an in vitro culture system utilizing skin cells
from neonatal IL-6 KO mice. This model allows for the
examination of the effects of this cytokine without the
confounding influence of endogenously produced cytokine.
We investigate the possible identity of an IL-6-induced
fibroblast-derived keratinocyte migratory factor by genomic
analysis, and the possible signaling pathways that may lead
to its induction.
Results
IL-6 is not a mitogen for keratinocytes A mechanism by
which IL-6 could affect wound healing is through increased
mitogenesis of epidermal keratinocytes. To test this
hypothesis, freshly isolated epidermal keratinocytes from
IL-6 KO mice were incubated with various concentrations
(0–500 ng per mL) of rmIL-6 or KGM for 16 h. DNA synthesis
was assessed by BrdU uptake using a commercially
available ELISA kit. KGM media induced significant DNA
synthesis in cultured keratinocytes compared to SFKGM
control (Fig 1). Treatment with rmIL-6 did not induce a
significant increase in BrdU incorporation at any of the
concentrations utilized in either SFKGM or KGM.
IL-6 indirectly modulates keratinocyte migration
through a soluble ﬁbroblast-derived motogenic factor
One of the primary activities of wound keratinocytes is
migration across the wound bed. IL-6 could affect this
process in either a direct manner, or indirectly by inducing
the production of migratory factors from nearby cells in the
dermis. Notably, the dermis contains numerous fibroblasts,
which upon wounding proliferate and are the primary cells
found in granulation tissue. To investigate this hypothesis,
freshly isolated keratinocytes were seeded into tissue
culture-treated transwell inserts (8 mm pore) and exposed
to KGM or various concentrations of rmIL-6, with or without
co-culture with fibroblasts. The cultures were allowed to
incubate for 16 h, and migrating keratinocytes were
determined by enumerating the cells that had migrated
across the porous membrane via light microscopy. Treat-
ment with rmIL-6 from 1 to 100 ng per mL did not induce
migration of keratinocytes across the transwell inserts (data
not shown). When keratinocytes from IL-6 KO mice are co-
cultured with dermal fibroblasts (also from IL-6 KO mice)
and exposed to rmIL-6 however, the keratinocytes readily
migrated across transwell inserts in the absence of collagen
or other matrix proteins (Fig 2). Culture supernatants
collected from overnight cultures of fibroblasts treated with
rmIL-6 also induce migration of keratinocytes (Fig 3). When
IL-6-treated fibroblast culture supernatants were heat
treated (1001C, 5 min), the motogenic potential of the
supernatants was completely abrogated (Fig 3).
One of the stimuli that induces keratinocyte migration is
contact with collagen I from damaged cell matrix in the
wound (Pilcher et al, 1997). Others have shown that IL-6
alone could induce keratinocyte migration across a collagen
matrix (Sano et al, 1999). To determine if FCM could
influence epidermal cell migration on a collagen matrix,
primary keratinocytes from IL-6 KO mice were prepared as
described above, and seeded onto 100 mm collagen I-
coated plates. Once confluent, the cells were serum and
growth factor starved for 8 h. An in vitro ‘‘wound’’ was
produced and the cells were incubated with 10 ng per mL
rmIL-6, FCM, or SFKGM for 24 h. Cells migrating across the
wound margin were enumerated in specific microscope
fields that had been designated and photographed the
previous day for comparison. As shown in Fig 4A and D,
rmIL-6 alone induced migration to a minor, but insignificant
degree when compared to serum-free media control. FCM,
Figure 1
IL-6 is not a mitogen for keratinocytes from IL-6 KO mice.
Epidermal keratinocytes were isolated from IL-6 KO mice, and seeded
on collagen I-coated 96-well plates. Cells were serum/growth factor
starved for 4 h, treatments were applied in quadruplicate, and
incubated 16–20 h at 371C and 5% CO2. Following incubation, 10 mL
of 0.1 mM BrdU was added to each well, and the plate incubated an
additional 8 h. BrdU uptake was determined by ELISA according to the
manufacturer’s instructions (Roche, Indianapolis, Indiana). Results were
obtained via an ELISA plate reader, and raw data expressed as
mean  SEM (n¼ 4) percent negative (non-treated) control.
Figure2
IL-6 induces keratinocyte migration indirectly through a dermal
cell-produced soluble factor. Dermal cells (primary fibroblasts) and
epidermal keratinocytes from IL-6 KO mice were cultured in 24-well
tissue culture dishes to approximately 80% confluency. Transwell
culture inserts (8 mm, tissue culture treated) were placed in the wells,
and IL-6 KO keratinocytes were seeded into the transwell enclosures.
Cultures were cultured in complete media (KGM), or treated with the
indicated concentrations of rmIL-6 for 16–18 h in serum-free/supple-
ment-free media (SFKGM) at 371C and 5% CO2. Following incubation,
transwell membranes were stained with hematoxylin, and migrating
cells were enumerated by light microscopy. Data are expressed
as meanþ /SEM (n¼ 7) number of cells counted in five random
fields when viewed at  20 magnification approximately 800 mm
(significantly different from serum-free media control, po0.05).
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however, induced significant migration across the wound
margin (Fig 4A and E).
One mechanism by which apparent migration could
occur is merely by spreading of keratinocytes as a result
of proliferation. To test this hypothesis, freshly isolated
epidermal keratinocytes from IL-6 KO mice were incubated
with SFKGM, FCM with or without 10 ng per mL rmIL-6, or
KGM media for 16 h. DNA synthesis was assessed by BrdU
uptake using a commercially available ELISA kit as
described above. The results of these assays showed that
neither non-treated nor IL-6-treated fibroblast culture
supernatants induced a significant mitogenic response from
keratinocytes as determined by DNA synthesis (Fig 5).
IL-6 does not promote mitogenesis or survival of
ﬁbroblasts in culture To determine whether the apparent
induction of a fibroblast-derived migratory factor was
associated with the proliferation or survival of dermal
fibroblasts in response to rmIL-6 treatment, cells were
assayed for DNA replication and viability by BrdU uptake
(ELISA) and WST (tetrazolium dye) assay respectively. As
shown in Fig 6, rmIL-6 did not induce mitogenesis of dermal
fibroblasts at concentrations ranging from 1 to 100 ng per
mL as determined by BrdU uptake (light bars). WST assay
showed a small but significant increase in cell activity at 1.0
ng per mL, but at higher concentrations (i.e., those
associated with keratinocyte migration), tetrazolium dye
metabolism was not significantly different from control (dark
bars).
The identity of the ﬁbroblast-derived keratinocyte
migratory factor could not be determined by genomics
analysis As shown in Fig 3, following heat treatment
(1001C for 5 min) IL-6-treated FCM lost all motogenic
activity, indicating that the migratory factor may be a
protein. In an attempt to identify the mRNA of this IL-6-
induced migratory factor, fibroblasts from IL-6 KO mice
were incubated for 2 h in the presence of 10 ng per mL
rmIL-6. This concentration of cytokine was determined as
optimal from transwell migration experiments (Fig 2). Total
cellular RNA was collected and gene array experiments
were conducted (Clontech Atlas Mouse 5k Array, cat
#7906-1, Clontech). Two identical genomics experiments
were carried out, the array data from identical treatments
were averaged utilizing the ‘‘average several arrays’’
function of Atlas Image (Clontech), and then gene expres-
Figure4
Dermal cell culture supernatants induce migration of keratinocytes
in an in vitro wound model. Keratinocytes from IL-6 KO mice, were
grown to confluency on collagen I-coated tissue culture plates. An in
vitro wound was administered to the culture (wound margin depicted as
dotted line). The cultures were washed and incubated in SFKGM
containing 10 ng per mL rmIL-6, or FCM for 24 h at 371C and 5% CO2.
Migrating cells were enumerated in three specific previously desig-
nated and photographed fields at  20 magnification approximately
800mm. (A) Data are expressed as means  SE (n¼ 4, significantly
different from SFKGM control, po0.05). Keratinocyte cultures imme-
diately after wounding: SFKGM (B) and FCM (C). Keratinocyte cultures
24 h following wounding: SFKGM (D) and FCM (E ).
Figure 3
Culture supernatants from rmIL-6 fibroblasts induce migration of
keratinocytes. Dermal cells from IL-6 KO mice were grown in 75 cm2
tissue culture flasks until approximately 80% confluence, and then
treated with the indicated concentrations of rmIL-6 for 16 h in SFKGM
at 371C and 5% CO2. IL-6-treated fibroblast culture supernatants
(FCM) were collected and 0.2 mm filtered. FCM was placed in the wells
of a 24-well plate, transwell culture inserts (8 mm, tissue culture treated)
were placed in wells of the plate, and IL-6 KO keratinocytes were
seeded into the transwell enclosures. Plates were allowed to incubate
for 16–18 h, after which the transwell membranes were removed, fixed,
stained with hematoxylin, and migrating cells were enumerated by light
microscopy. Data are expressed as mean  SEM (n¼ 4) number of
cells counted in five random fields when viewed at  20 magnification
approximately 800mm (significantly different from SFKGM control,
po0.05).
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sion differences between treatments were determined also
utilizing Atlas Image. A gene that varied in expression  2-
fold was judged to be modulated by treatment. Once
candidate genes were identified by this method, the
individual candidate gene spots on each array were
examined, and RT-PCR analysis was performed for specific
genes to eliminate false positives. Analysis of the arrays in
this manner did not indicate that rmIL-6 treatment modu-
lated any genes currently identified as soluble keratinocyte
migration factors, and these findings were confirmed by RT-
PCR analysis (Tables I and II).
IL-6 induces phosphorylation of STAT3, but not ERK or
Akt in dermal ﬁbroblast from IL-6 KO mice The signal
transduction pathway of the IL-6 receptor (IL-6R) is
complex and involves essentially three pathways: JAK/
STAT3, ERK1/2, and the more recently described PI3K/Akt
pathway. To determine which pathway might be predomi-
nantly stimulated by rmIL-6 in IL-6 KO fibroblasts, dermal
cells were exposed to the cytokine at various time points,
and nuclear protein was isolated from fibroblast cultures.
Quantitation of phospho-STAT3, ERK1/2, and Akt proteins
was accomplished by western blot. From these analyses, it
was found that STAT3 was phosphorylated in a time- and
concentration-dependent manner, whereas the phosphor-
ylation state of ERK1/2 and Akt did not appear to be
affected by rmIL-6 treatment (Fig 7).
Discussion
IL-6-deficient mice display greatly impaired wound healing
as evidenced by delayed wound closure, decreased
inflammation, granulation tissue formation, neovasculariza-
tion, and incomplete re-epithelialization (Gallucci et al,
2000; Lin et al, 2003). This impairment was noted for as
long as 15 d, nearly triple the normal healing time. IL-6 KO
mice express normal levels of functional IL-6 receptor (Kopf
et al, 1994), and wound healing could be reconstituted by
treating IL-6 KO mice with rmIL-6 (Gallucci et al, 2001a; Lin
et al, 2003) or an IL-6 expression plasmid (Gallucci et al,
2001a).
While these results indicate that IL-6 is intimately
involved in the wound-healing process, they do not provide
Figure 5
Dermal culture supernatants do not induce proliferation of
keratinocytes. Epidermal keratinocytes from IL-6 KO mice were
seeded onto collagen I-coated 96-well culture plates and allowed to
adhere for 4 h. The cells were washed twice with PBS and treatments
were added in quadruplicate as indicated, and incubated for 16–18h.
Following incubation, 10 mL of 0.1 mM BrdU was added to each well,
and the cells were then incubated an additional 8 h. Medium was then
aspirated from the wells and ELISA determined BrdU uptake according
to the manufacturer’s instructions (Roche). Results were obtained via
an ELISA plate reader, and raw data expressed as mean  SEM (n¼4)
percent negative (non-treated) control (significantly different from
SFKGM control, po0.05).
Figure 6
IL-6 is not a mitogen fibroblast from IL-6 KO mice. Dermal
fibroblasts isolated from IL-6 KO mice were seeded at 1  104 per
well on tissue culture-coated 96-well plates. The cells were serum/
growth factor starved for 4 h, and treatments were applied in
quadruplicate. Cells were incubated 16–20 h at 371C and 5% CO2.
BrdU or WST reagent (Roche) was added to the wells according to the
manufacture’s instructions. The plates were incubated an additional 3 h
(WST) or 8 h (BrdU), and the assays were completed according to the
manufacturer’s instructions. Results were obtained via an ELISA plate
reader, and raw data expressed as mean  SEM (n¼4) percent
negative (SFKGM) control. Light bars¼BrdU, dark bars¼WST1
reagent (significantly different from SFKGM control, po0.05).
Table I. Common soluble keratinocyte migratory factors.
Factor References
Tgf b Santibanez et al (2000), Sarret et al (1992), Zambruno
et al (1995)
EGF Ando and Jensen (1993), Chen et al (1993), McCawley
et al (1998), Sarret et al (1992)
Fgf 7 Ando and Jensen (1993), Tsuboi et al (1992)
Fgf 10 Cha et al (1996), Gibbs et al (2000), Matsumoto et al
(1991), Sato et al (1995), Tsuboi et al (1993), Tsuboi
et al (1992)
Hgf Gibbs et al (2000), McCawley et al (1998), Putnins et al
(1999), Sato et al (1995), Tsuboi et al (1992)
Tgfa Cha et al (1996), Jimenez and Rampy (1999),
Tokumaru et al (2000)
Igf-1 Dunsmore et al (1996), McCawley et al (1998), Sato
et al (1995), Tsuboi et al (1992)
GM-CSF Aragane et al (1996), Barrandon and Green (1987),
Cha et al (1996), Chen et al (1993), Ghahary et al
(1998), Jiang et al (1993), Tsuboi et al (1992)
IL-1 Ando and Jensen (1993), Chen (1995), Tsuboi
et al (1992)
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information concerning the mechanism of IL-6 during the
process of re-epithelialization. IL-6 could modulate re-
epithelialization by directly acting on keratinocytes, inducing
mitogenesis or migration. It might also act indirectly by
inducing the expression of various keratinocyte-derived
factors in an autocrine or paracrine fashion. Previous
studies, however, concerning the effects of IL-6 on
keratinocyte proliferation offer conflicting results (Grossman
et al, 1989; Elder et al, 1992; Oyama et al, 1998; Sawamura
et al, 1998; Sato et al, 1999). Recent experiments utilizing
normal human epidermal keratinocyte (NHEK) cultures
(Sugawara et al, 2001), and those presented in this article
(Fig 1), did not demonstrate that IL-6 was a keratinocyte
mitogen, agreeing with studies by Elder et al (1992) and
Oyama et al (1998). Thus, it seems that IL-6 may not directly
induce keratinocyte mitogenesis. This does not preclude
the possibility of IL-6 acting in an indirect fashion though.
Indeed, IL-6 can induce KGF expression in fibroblasts
(Brauchle et al, 1994; Chedid et al, 1994), and EGF receptor
in keratinocytes in vitro (Oyama et al, 1998), both of which
would induce keratinocyte proliferation. Herein we show
that culture supernatants collected from IL-6-treated IL-6
KO fibroblasts do not induce significant proliferation of
cultured epidermal cells from IL-6 KO mice (Fig 5), further
indicating that this cytokine does not indirectly mediate the
mitogenesis of keratinocytes.
Another possible mechanism by which IL-6 may influ-
ence re-epithelialization is through the modulation of
keratinocyte migration. While both proliferation and migra-
tion of keratinocytes contribute to re-epithelialization, they
appear to be two separate events. For example, in vitro
keratinocyte migration occurs early, after only 2–3 h, as
compared to mitogenesis, which requires at least 24 h (Cha
et al, 1996; O’Toole et al, 1997). Additionally, TGFb is well
known to induce keratinocyte migration, while it greatly
inhibits proliferation (Sarret et al, 1992; Garlick and Taich-
man, 1994). One of the primary observations from our
preliminary experiments involving IL-6 KO mice was that
while the leading edge of the wounded epithelium displayed
some thickening (perhaps indicating some mitogenesis was
occurring in the absence of IL-6), it also showed profoundly
decreased migratory activity, which was restored by rmIL-6
treatment (Gallucci et al, 2000). Herein we show that this is
also true in vitro. When keratinocytes from IL-6 KO mice are
co-cultured with dermal cells (also from IL-6 KO mice) and
exposed to rmIL-6, the keratinocytes readily migrated
across transwell inserts in the absence of collagen or other
matrix proteins (Fig 2). If either rmIL-6 is not present in the
culture media, or the keratinocytes are not co-cultured with
dermal cells, no migration was apparent. Paradoxically, we
show that at concentrations greater than 10 ng per mL, the
migratory effects of rmIL-6 appear to decrease (Figs 2 and
3), which seems to indicate feedback inhibition. This may
not be surprising, since prolonged stimulation of IL-6Ra
results in decreased receptor signal transduction through
various inhibitors such as protein inhibitors of activated
STAT (PIAS) and suppressors of cytokine signaling (SOCS)
(for a review, see Heinrich et al, 2003). What role these
inhibitors of IL-6R signal transduction play in keratinocyte or
fibroblast function, or wound healing in general, is yet to be
elucidated.
The structure and function of IL-6 and its receptor has
been thoroughly reviewed elsewhere (Heinrich et al, 2003).
Table II. IL-6-induced ﬁbroblast expression of common soluble migratory factor genes
IL-6 induced gene expression (% control)
Factor Arraya RT-PCRb RT-PCR primer sequence
Tgfb 100 101 (  3.0) 50-tggaccgcaacaacgccatctatgagaaaacc, 50-tggagctgaagcaatagttggtatccagggct
EGF 100 110 (  4.3) 50-tgttcatcgcctgacaatgg, 50-gatgatgcttcccgctcagat
Fgf 7 100 99.0 (  4.0) 50-cataggtgttataatggttttc, 50-atactgacacggatcctgcca
Fgf 10 100 115 (  9.4) 50-tccagtgccgagagtttcagt, 50-tggctttgacggcaacaac
Hgf 100 100 (  1.2) 50-tgcgctcacagtgctgtgaa, 50-ttcaatttgctagcatctgg
Tgfa n/a 102 (  2.3) 50-acctgcaggtttttggtgcag, 50-ggagggcgctgggcttctcg
Igf-1 100 108 (  3.6) 50-agctggtggatgctcttcagtt, 50-gcggtgatgtggcattttct
GM-CSF 100 110 (  5.1) 50-tgtggtctacagcctctcagcac, 50-caaaggggatatcagtcagaaaggt
IL-1b 100 95.1 (  6.1) 50-gaaatgccaccttttgacag, 50-caaggccacaggtattttgt
aaverage of two arrays, n/a—gene not available on array.
bn¼3,  SE.
Figure 7
IL-6 induces phosphorylation of STAT3 in fibroblasts from IL-6 KO
mice. Primary dermal fibroblasts from IL-6 KO mice were grown to
80% confluence on 150 mm tissue culture plates, and serum/growth
factor starved for 6 h. Treatments were applied as indicated. Nuclear
protein was isolated from the treated cultures at the indicated time
points. Western blot analysis was performed on 25 mg of nuclear
protein, and bands were detected with anti-phosphoprotein antibodies
(Cell Signaling, Beverly, Massachussets). Blots were imaged via an
Odyssey fluorescent imager (LiCor, Lincoln, Nebreska). Photographs
are representative of three identical experiments.
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Briefly, IL-6R is multimeric, and composed of two basic
subunits. The a subunit does not contain signal-transducing
elements, whereas the b subunit (gp130) is known to
primarily mediate signal transduction, leading to the
activation of at least three different signaling paths: JAK/
STAT3, ERK/MAPK, and PI3/Akt. To determine which IL-6R/
gp130 signal transduction pathway might be activated by
IL-6 treatment of fibroblasts, the phosphorylation states of
STAT3, ERK1/2, and Akt from IL-6 KO dermal cells were
analyzed. As shown in Fig 7, neither ERK1/2 nor Akt were
significantly modulated in primary dermal fibroblasts by
exposure to rmIL-6. There was a robust activation, however,
of STAT3 in fibroblasts that occurred approximately 5 min
following treatment, and remained high out to 1-h post-
treatment. This seems to indicate that the STAT3 pathway is
associated with IL-6-induced fibroblast modulation of
keratinocyte migration. Interestingly, STAT3-deficient mice
also display impaired wound healing similar to IL-6 KO
mice. Sano et al (1999) reported that while migration was
impaired, proliferative activity of keratinocytes from STAT3-
deficient mice was not affected. This group also reported
that cytokines that activated STAT3, such as EGF and IL-6,
could induce the migration of keratinocytes in vitro on a
collagen I matrix, and that the deletion of STAT3 abrogated
the motogenic potential of these factors. We have also
found that IL-6 can directly induce a moderate (although not
statistically significant) amount of migration in keratinocytes
from IL-6 KO mice (Figs 4a and d) on collagen I-coated
tissue culture plates. We show, however, that FCM induced
a significantly more robust migratory response from
keratinocytes on collagen I than IL-6 alone (Figs 4a and
e), and as stated above we have also found that IL-6-
mediated migration of keratinocytes on tissue culture-
treated plastic can only be induced upon co-culture with
dermal fibroblasts (Fig 2). This indicates that, in response to
IL-6 stimulus, fibroblasts produce factors that can com-
pensate for the absence of migratory stimulus from cell
matrix contact, or perhaps induce matrix formation by
keratinocytes.
The physical separation of keratinocytes and fibroblasts
in the transwell assay indicates that dermal cells are
producing a soluble migratory mediator as a result of
treatment with IL-6. A number of soluble factors have been
identified, which influence keratinocyte migration in vivo
and in vitro. While TGFb is probably the most studied, and
has been shown to increase keratinocyte migration in vivo
and in vitro, there are other growth factors and cytokines
that have been shown to induce migration as well (Table I).
In an attempt to identify this IL-6-induced migratory factor,
fibroblasts from IL-6 KO mice were incubated with rmIL-6,
and mRNA was isolated from these cells and analyzed by
microarray. To rule out the possibility of false positive or
negative data, the expression of known migratory factors
were confirmed by RT-PCR (Table II). Unfortunately, none of
the genes currently identified as a soluble keratinocyte
migratory factor were modulated by IL-6 treatment (Table II).
It should be taken into account, however, that the genomic
data presented herein represent only one time point
following IL-6 exposure. Since the keratinocyte migration
assays were allowed to occur over a 16-h period, it is
possible that the migratory factors are modulated at a later
time point. It is also possible that IL-6 may upregulate a
receptor on keratinocytes for a factor that is constitutively
expressed by fibroblasts, or induce a keratinocyte-derived
factor that modulates fibroblast activity or function, which
ultimately results in keratinocyte migration. Thus, it may be
possible to elucidate the migratory factor with further
genomic analysis of IL-6-stimulated dermal and epidermal
cells. Experiments are currently underway to investigate this
possibility. Additionally, while the factor is most likely a
protein based on its sensitivity to heat denaturation (Fig 3),
the activity of the migratory factor may not be associated
with its transcriptional regulation. It could be that this factor
is released preformed from intracellular stores, or perhaps
modified from an inactive form to an active form by an
enzyme that is in turn modulated by IL-6. In these scenarios,
genomics analysis would miss these processing events and
proteomic analysis would be necessary to identify the
factor.
One mechanism by which IL-6 might appear to be
influencing the expression or activity of a migratory factor is
merely by promoting the survival of the cells of origin. The
net result of this would be an increase in the concentration
of the migratory factor in cultures treated with the cytokine,
even though the cytokine itself did not specifically affect the
mRNA or protein expression level of the factor. IL-6 seems
to have varying effects on cells of fibroblast lineage, which
appears to be associated with the anatomical origin of the
cells. For instance, IL-6 induces the angiotensin-II-induced
proliferation of cardiac fibroblasts (Sano et al, 2000), while it
inhibits the proliferation of synovial (Nishimoto et al, 2000)
and dermal fibroblasts (Mihara et al, 1996). Our data agree
with the later study, and show that IL-6 does not induce the
proliferation of dermal fibroblasts as determined by BrdU
uptake (Fig 6). While it does not seem to promote
mitogenesis however, it may affect the differentiation or
survival of these cells.
As stated above, IL-6 readily induces STAT3 activation in
fibroblasts (Fig 7), and constitutively expressed STAT3 has
been shown to protect fibroblasts from the apoptotic effects
of UV irradiation, serum starvation, and STAT1 activity (Shen
et al, 2001), and can downregulate Fas expression in
fibroblast cell lines (Ivanov et al, 2001). When examined by
tetrazolium dye assay however, which is a measure of
energy expenditure and cell viability, IL-6 did not have a
significant effect on fibroblast survival at the concentrations
(410 ng per mL), which produced appreciable keratinocyte
migration (Fig 6). Interestingly, the lowest concentration
(1.0 ng per mL) induced a small but significant increase in
cell viability. The implications of this finding are not yet
known.
In conclusion, our results indicate that IL-6 has obvious
indirect effects on the modulation of keratinocyte motility.
This complex mechanism appears to involve a novel
interaction between dermal and epidermal cells, and
the interplay of an as yet unidentified soluble fibroblast-
derived factor(s). While the STAT3 signal transduction
pathway seems to be activated in fibroblasts by IL-6
treatment, further studies will be necessary to determine
the exact nature of the mechanism of this cytokine on
fibroblast function, gene regulation, and its relation to
wound healing.
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Materials and Methods
Keratinocyte isolation IL-6 KO mice were housed in an AAALAC
accredited facility, and all procedures involving animals were
reviewed and approved by the OUHSC Institutional Animal Care
and Use Committee. All operations were performed using the
aseptic technique unless otherwise noted. Keratinocytes from the
skin of neonatal IL-6 KO or wild-type C57 pups were isolated
essentially as by the method of Hager et al (1999). Briefly, newborn
mouse pups (0–48 h old) were euthanized by decapitation, rinsed
in 70% ethanol, and the skin was removed. Skins were incubated
dermis down in culture dishes containing HBSSþ 3.6% dispase
(Sigma, St Louis, Missouri) overnight at 41C. The epidermis was
separated from the dermis and placed in a tube containing fresh
0.25% trypsin, vortexed vigorously, and incubated for 10 min at
371C. Epidermal cells were dispersed by repeated aspiration with a
pipettor and filtered through a sterile gauze pad into a 50 mL
conical tube. An equal volume of low calcium, complete
keratinocyte growth medium (KGM, Cascade Biologics, Portland,
Oregon) was added to the epidermal keratinocytes, and the cells
were centrifuged at 200  g for 10 min. Keratinocytes were
resuspended in growth medium, plated at 6–10  103 per cm2
on rat tail collagen 1-coated 100 mm culture dishes (Becton
Dickinson, Franklin Lakes, New Jersey), and incubated at 371C and
5% CO2 and 95% room air.
Dermal ﬁbroblast isolation The dermis was collected and
separated from the epidermis as stated above. The dermis was
placed in HBSSþ 0.05% Type 1 collagenase and incubated at
371C for 30 min with constant agitation. The cell suspension was
filtered through sterile gauze into a 50 mL conical tube. An equal
volume of DMEMþ 5% FBS containing, 60 IU per mL penicillin,
100 IU per mL streptomycin, and 4 mM glutamine (DMEMþ 5%)
was added and centrifuged at 200  g for 10 min. Fibroblasts were
resuspended in DMEMþ 5%, plated at 8  103 per cm2 in 150 mm
culture dishes, and incubated at 371C and 5% CO2 and 95% room
air. To produce IL-6-treated fibroblast-conditioned medium (FCM),
fibroblast cultures were serum starved for 2 h, washed twice with
HBSS, and incubated 24 h in SFKGMþ 10 ng per mL rmIL-6. The
resulting medium was collected, sterile filtered, and stored at
701C until use.
Proliferation assays Dermal and epidermal cells were isolated
and cultured as described above. Cells were seeded at 1  104 per
well on collagen I-coated (keratinocytes) or tissue culture-treated
(fibroblasts) 96-well plates. Cells were allowed to adhere to the
plates overnight in complete media at 371C and 5% CO2 and 95%
room air. The cells were serum/growth factor starved for 4 h, after
which treatments were applied in quadruplicate. The cells were
incubated 16–20 h at 371C and 5% CO2 and 95% room air, and
either WST or BrdU (Roche, Indianapolis, Indiana) was added to
the wells according to the manufacturer’s instructions. The plates
were incubated for an additional 2 (WST) or 8 h (BrdU), and the
assays were completed according to the manufacturer’s instruc-
tions. Results were obtained via an ELISA plate reader, and raw
data were expressed as percent negative (non-treated media)
control.
Transwell migration assay Primary fibroblasts from IL-6 KO mice
were seeded into 24-well tissue culture plates at 4  103 per cm2 in
DMEMþ 5% and allowed to adhere overnight at 371C and 5%
CO2. The following day, medium was aspirated from the 24-well
plate containing fibroblasts. The plate was washed twice in HBSS,
and allowed to incubate in 0.5 mL of HBSS at 371C and 5% CO2
for 1 h. Primary keratinocytes from IL-6 KO mice grown to 80%
confluency on collagen I-coated tissue culture plates were
resuspended in serum-free/growth supplement-free keratinocyte
growth media containing 1 mg per mL BSA, 60 IU per mL penicillin,
and 100 IU per mL streptomycin (SFKGM). The rationale for using
serum-free/supplement-free media was to minimize the effects of
growth factors in the serum and supplements, which could
confound the cell’s response to added migratory factors. Serum-
free/supplement-free medium is routinely used in keratinocyte
migration assays (Matsumoto et al, 1991; Cha et al, 1996; Sano
et al, 1999; Gibbs et al, 2000; Tokumaru et al, 2000). 2.0  104
keratinocytes were added to sterile microfuge tubes and cen-
trifuged at 500  g for 5 min. Medium was aspirated from the cell
pellets and each was resuspended in 100 mL of either KGM, or
SFKGM containing specific concentrations of rmIL-6. HBSS was
aspirated from the 24-well plate, containing fibroblasts, and 500 mL
of the identical treatments administered to the keratinocytes were
added to specified wells. Transwell inserts (8 mm pore, 5 mm
diameter) were placed in wells of the plate, and 100 mL of
keratinocytes were added to each well corresponding to the
correct treatments. Transwell plates were incubated for 16 h at
371C and 5% CO2. After incubation, cells were removed from the
top of the insert membrane by gently swabbing the membrane with
a sterile cotton swab. The membrane was rinsed twice with PBS,
and aspirated to assure removal of cells. The transwell inserts were
removed from the plate and placed in fixative (10% buffered
formalin) overnight at room temperature. Inserts were washed
once in saline immersed in a 1% hematoxylin solution overnight at
41C, and then rinsed twice in saline. The membrane was removed
from the transwell, dried, and mounted on a glass microscope
slide. Migrating cells were visualized by light microscopy, and
enumerated by counting five random fields at  20 magnification
in a blinded fashion.
In vitro wound assay Keratinocytes were prepared as described
above, and 5  105 cells were added to 100 mm collagen I-coated
tissue culture plates (Becton Dickenson) in KGM at 371C and 5%
CO2. Once confluent, an in vitro wound was produced on the
culture essentially as described by Mathew et al (1997). Briefly,
the edge of a sterile razor blade was pressed lightly against the
confluent monolayer of cells. A sterile rubber policeman was then
used to sweep away the monolayer on one side of the blade. The
razor’s edge not only acts as a barrier and straight edge to facilitate
cell removal, but the blade produces a distinct wound border that
facilitates easy enumeration of cells that migrate beyond the
margin. The cultures were washed three times in PBS, and then
incubated in SFKGM containing 10 ng per mL rmIL-6, FCM, or no
treatment. After 24 h incubation at 371C and 5% CO2, migrating
cells were enumerated by counting three fields at  20 magnifica-
tion that were designated as previously having a cell-free in vitro
wound margin immediately after wounding.
Clontech Atlas Gene Array Dermal or epidermal cells were
isolated as described above and allowed to become approximately
50%–70% confluent. Cell culture was then treated with either 10
ng per mL recombinant mouse IL-6 (rmIL-6, Invitrogen, Baltimore,
Maryland) or an equal volume of saline for 120 min. This dose and
time period were previously determined as sufficient for gene
induction (Sugawara et al, 2001). Cells were collected and total
cellular RNA was extracted using the Qiagen RNeasy kit (Qiagen,
Valencia, California) according to the manufacturer’s procedure. An
aliquot of total RNA (25–50 mg) was further purified for mRNA,
reverse transcribed, and 32P labeled using the Clontech Atlas Pure
RNA labeling kit (Clontech, Palo Alto, California) according to the
manufacturer’s instructions. Radiolabeled cDNA was then hybri-
dized to the Atlas (Clontech Mouse 5k Array) plastic membrane for
20 h. The membrane was washed and exposed to a phosphor-
imager screen for 24 h. The phosphorimager screen was then
scanned using a Storm 820 phosphorimaging system (Molecular
Dynamics, Sunnyvale, California). Results were determined using
AtlasImage software (Clontech). A 2-fold difference in gene
expression was considered to be significant.
Semi-quantitative RT-PCR reaction Total cellular RNA was
extracted from keratinocyte or fibroblast culture using the Qiagen
RNeasy kit (Qiagen, Valencia, California) according to the
manufacturer’s instructions, and quantitated spectrophotometri-
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cally. Total RNA was reverse transcribed into cDNA as described
previously (Simeonova and Luster, 1995) and the reaction mixture
was diluted with RNase-free water to 50 mL. PCR primers for
G3PDH were purchased from Clontech. Primers for mouse genes
were custom synthesized (Life Technologies, Bethesda, Maryland)
from sequences presented in Table I. Samples of cDNA were
amplified via PCR as previously described (Bruccoleri et al, 1997).
Amplified PCR products were electrophoresed in 1.5% agarose gel
and scanned directly with a DigiDoc digital imaging system (UVP,
Upland, California). The digital images were analyzed using NIH
Image v1.57, and mRNA semi-quantitative values were normalized
based on G3PDH expression.
Western blot analysis Fibroblasts were prepared as described
above, and cultured to 90% confluency in 150 cm2 culture plates.
Prior to treatment, fibroblast cultures were washed twice with PBS,
and culture medium was replaced with serum-free DMEM contain-
ing 1 mg per mL BSA, 60 IU per mL penicillin, 100 IU per mL
streptomycin, and 4 mM glutamine. Following a 4 h incubation in
serum-free media, treatments were applied to the cultures in fresh
serum-free DMEM. At specific time points, two culture plates were
rinsed once with ice-cold PBS, and cells were collected by the use
of a cell scraper into ice-cold PBS. Cells were centrifuged at
400  g at 41C for 5 min, and nuclear protein was isolated from the
cell pellet utilizing a Mercury Transfactor Extraction Kit (BD/
Clontech) according to the manufacturer’s instructions. Nuclear
protein (25 mg) was electrophoresed utilizing 10% SDS-PAGE (10
cm  10 cm) minigels (Gradipore, Frenchs Forest, AUS) at 90 V for
45 min, and electrophoretically transferred onto nitrocellulose
sheets (Pierce, Rockford, Illinois) at 25 V for 2.5 h. Following
transfer, the blots were blocked in Tris-buffered saline containing
1% cold-water fish gelatin (Sigma), and 50 mM NaF for 1 h at RT.
The blots were then exposed to rabbit anti-phospho-ERK1/2, anti-
phospho-STAT3, or anti-phospho-Akt (Cell Signaling Technology,
Beverly, Massachussets), at a 1:1000 dilution in TBS containing
1% fish gelatin, 0.1% Tween 20, and 50 mM NaF overnight at 41C.
The blots were washed 3  in TBS containing 0.1% Tween 20, and
exposed to a fluorescently labeled (IRDye 800) secondary anti-
rabbit polyclonal antibody (Rockland, Gilbertsville, Pennsylvania) at
a 1:20,000 dilution in TBS containing 1% fish gelatin, and 0.1%
Tween 20 for 1 h. Following three washes in TBSþ 0.1% Tween,
the blots were imaged via an Odyssey infrared imaging system (LI-
Cor, Lincoln, Nebraska).
Statistical analysis All experiments were replicated and repre-
sentative findings were shown. Statistical significance was
determined by one-way ANOVA. When the F value was significant,
the means were compared using Fisher post hoc analysis. In all
statistical comparisons, a p value of less than 0.05 was used to
indicate a significant difference.
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